The SNP Genotyping and Analysis Market size is expected to grow at an annual average of 20% during 2021-2027. Single Nucleotide Polymorphism (SNP) genotyping is a measure of genetic variation. It is the most common type of genetic variation among humans. Certain single base pair mutations are ideal for identifying correlations between genotype and human behavior.SNP analysis has become an attractive and convenient method to study DNA sequence variation. The market is likely to record double-digit growth rates as more microarrays containing more DNA probes enter the market.
(Get 15% Discount on Buying this Report)
A full report of SNP Genotyping and Analysis Market is available at: https://www.orionmarketreports.com/snp-genotyping-and-analysis-market/39191/
The following segmentation are covered in this report:
By Application:
- Pharmaceuticals and Pharmacogenomics
- Diagnostic Research
- Agricultural Biotechnology
- Breeding and Animal Livestock
By Technology:
- SNP Microarray
- Taqman Allelic Discrimination
- SNP Pyrosequencing Technologies
- ABISNPlex
- Sequenom Mass-Array MALDI-TOF
- Others
Company Profile
- Sequenom, Inc.
- Douglas Scientific LLC
- PREMIER Biosoft
- Luminex Corp.
- Life Technologies Corp.
- Fluidigm Corporation
- Illumina, Inc.
- Affymetrix, Inc.
- Promega Corporation
- Thermo Fischer Scientific Inc.
The report covers the following objectives:
- Proliferation and maturation of trade in the global SNP Genotyping and Analysis Market
- The market share of the global SNP Genotyping and Analysis Market supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the SNP Genotyping and Analysis Market
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global SNP Genotyping and Analysis Market
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
